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Abstract 
3D tissue constructs offer a simplified model that mimics the in vivo tissues. Standing post 
platform has been established in this study to fabricate 3D tissues with a variety of shapes. 
Non-fouling PDMS molds cast from ABS templates were seeded by cell-laden collagen type 
I scaffolds. The scaffolds were aggregated to form the tissues within 24 hours. Human 
fibroblast, hiPSC-CM, and hiPSC-MSC tissue rings were successfully fabricated with this 
standing post platform. Ring contracture of fibroblasts and hiPSC-MSCs was observed and 
compared with different collagen density, different cell seeding density, and different cell 
culture concentration. In addition, the tissue constructs could also be cultured with serum-free 
media. By increasing the number of the standing posts, oval and triangle-shaped hiPSC-MSC 
tissue constructs have been also created. Macroscopically morphological changes were 
recorded and compared. With these results, the standing post platform was proven its 
consistency to fabricate tissue constructs, and ready to be used across different cell types 
suitable for quantitative analysis. 
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1.1. Overview of Tissue Engineering 
The goal of tissue engineering is to create native-like tissues by using the combination 
of cells, materials, and biological cues1. The technological importance of tissue engineering is 
to study human-specific tissue development and diseases in living matters2–4 and to 
understand the complexity of biological mechanism on the tissue level5–7. Engineered in vitro 
models starts from 2D models, which have great reproducibility but lack of informational 
accuracy since native tissues are 3D8. On the other hand, although studies based on living 
animals produces physiological information9, it is difficult to quantitatively and consistently 
analyze the results to high variation of test subjects. Therefore, 3D tissue models offer us the 
opportunities to improve the experimental reproducibility, reduce the cost of animal testing, 
test with human cells, and provide the information that is absent in 2D models10,11. 
Conventionally, 3D tissue constructs are created by seeding biological cells into the 
biomaterial scaffolds fabricated by different methods. The advantages of tissue constructs are 
as follows: (1) The constructs can be formed by defined cell compositions, either from 
primary cells harvested from human and animals, or from immortal cells lines, such as 
fibroblasts (3T3)12–14, endothelial cells (HUVEC)15–17, smooth muscle cells (C2C12)18–20, 
etc.; (2) The tissue constructs offer simplified models to investigate fundamental biological 
questions, while also can increase the model complexity via different techniques; (3) The 
tissue constructs can be used to emulate native developmental processes, such as wound 
healing21–23 and muscle development19,24,25; (4) The tissue constructs are readily accessible 
for studying tissue mechanics, structure and functions; and (5), The tissue constructs are 
reproducible and scalable in both size and quantity26. 
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However, tissue constructs also have disadvantages, which needs to be addressed in 
many research fields. The tissue constructs are fundamentally different from the native 
biological tissues. They are a simplified version of real organ/tissue because the constructs 
only contain specific types of cells and lack appropriate cellular interactions occurred in the 
native tissues. For instance, although, the majority of cells in hearts are cardiac muscle cells 
and fibroblasts that can be recreated in vitro, the incorporation of endothelial cells will need 
to be addressed to produce both vascularization and soluble biochemical products that can 
impact heart function and development. Moreover, dissimilarity in cell density and 
mechanical properties of the tissue constructs and targeted biological tissues can lead to the 
functional differences. Currently, one major challenge of tissue engineering is the lack of 
supportive infrastructures, such as vascular system, in the tissue constructs, which will result 
in insufficient nutrients and oxygen delivery available to the constructs 26. 
1.2. Engineering Tissue Rings 
Among all the tissue constructs, ring-shaped tissue constructs offer several advantages 
over conventional sheet-shaped tissue constructs: (1); The ring-shaped tissue constructs offer 
even force distribution leading to measuring precision since the designs circumvent force 
concentration in the center unlike other designs27,28;  (2) The ring-shaped tissue constructs are 
easier to be handled and sutured to the damaged native tissues with standard clinical 
procedures; (3) Specifically for cardiac tissue engineering, the ring-shaped constructs could 
potentially be used to mimic the structural feature of ventricular tissue sections for further 
analysis on contractile behaviors in a biomimetic manner. A network of ring-shaped 
constructs could be used to emulate human organs, such as vasculature and trachea, since a 
ring-shaped tissue could mimic the cross section of these organs for understanding their 
physiological and mechanical functions.  
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1.2.1. Muscle Tissue Rings 
Coronary artery bypass grafting surgery (CABG), a surgery aiming to restore normal 
blood flow by replacing a problematic section of an artery, is performed hundreds of 
thousands of times yearly in United States29–31. One in three patients is not suitable for 
autologous surgery because of the lack of available artery32. Vascular tissue engineering is a 
way to help these patients by fabricating such an artery. Vascular tissue engineering also may 
provide a suitable model for studying heart diseases. Scaffold-free tissue ring fabrication has 
been presented for vascular tissue engineering32.  In summary, the protocol is as follow: (1) 
Polycarbonate template is created by traditional milling process; (2) Polydimethylsiloxane 
(PDMS) mold is fabricated by adding the polymer at a ratio of (10:1) (w/w) into the 
polycarbonate template. The PDMS mold will be ready after curing at 60°C for 4 hours; (3) 
Agarose mold is cast using the PDMS mold; (4) cells are seeded into the agarose mold; (5) 
Media is exchanged every other day beginning from 24 hours after the seeding; (6) A 
consistent ring should be formed within 7 days. The protocol is illustrated in Figure 1.  
This protocol can be used with various types of cells, such as rat smooth muscle cells 
(rSMCs) and human smooth muscle cells (hSMCs) by adjusting the protocol. The tissue rings 
with different cells resulted in different morphology, matrix composition, and mechanical 
properties. By performing tensile strength testing, they found Day-14 0.66 million rSMCs 
rings were stronger and thicker than Day-7 0.5 million rSMCs rings and Day-14 0.75 million 
hSMCs rings (97 ± 30 vs 113 ± 8 vs 160 ± 30 kPa for UTS (ultimate tensile strength) and 
0.94 ± 12 vs 0.53 ± 0.02 vs 0.51 ± 0.05 mm for thickness). hMSCs rings were fabricated 
and broken during initial pre-cycling phases of uniaxial tensile testing due to the lack of 
mechanical strength. However, the protocol possesses several drawbacks: (1) the method 
depends largely on the operator; (2) the agarose mold is not reusable, so each cell seeding 




Figure 1. Scaffold-free tissue ring fabrication protocol32.  (A) Schematic of fabrication 
method, (B) Polycarbonate mold with 2 mm pole; scale bar = 6 mm, (C) PDMS template 
after casting; scale bar = 6 mm (D) Agarose well with tissue ring; scale bar = 6 mm, (E) A 
tissue ring in PBS; scale bar = 2 mm 
1.2.2. Mesenchymal Stem Cell Tissue Rings 
Mesenchymal stem cells (MSCs) are immune-evasive multipotent stromal stem 
cells33. MSCs can be acquired from sources such as bone marrow, cord cells, adipose tissue, 
molar cells, etc. MSCs can give rise to many lineages such as bone, fat, chondrocyte, muscle, 
neuron, islet cells, and liver cells34.  Because of harvest and differentiation potentials, MSCs 
offer a bright future, but studies need to be performed before using them clinically, especially 
studying on differentiation pathway and immune modulation. 
MSCs are also located at perivascular locations surrounding blood vessels (on both 
arterial and venous vessels) in the bone marrow35, thus 3D MSC tissue ring and tube might be 
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suitable to mimic native morphology and behavior in vitro. Additionally, hMSC-derived 
cartilaginous tissue rings were fabricated with the final goal of creating tissue tubes with 
multiple rings36. The fabrication protocol was improved by the agarose devices for increasing 
throughput of tissue rings from one single mold. The cells were seed with TGFβ-loaded 
microspheres to fabricate the hMSC rings as depicted in Figure 2. The microspheres helped 
to produce thicker and darker hMSC tissue rings than their counterpart as shown in Figure 3. 
In the mechanical testing, hMSC and hMSC + microspheres tissue tubes had equal and higher 
maximum load and tensile strength compared to the native rat trachea.  
 
Figure 2. Tissue ring and tube fabrication diagram36. hMSCs + growth factor loaded 
microsphere were loaded into agarose wells. The rings were taken out on day 2 to 
manufacture tissue tubes by stacking tissue rings on silicon tubes. (A) hMSCs rings and (C) 
hMSCs + microsphere rings were in agarose well outlined by white dots with 2 mm post 
outlined by black dots. (D) hMSCs tubes and (D) hMSCs + microsphere tubes were produced 
by stacking 3 rings (white arrow) and 6 rings (black arrow) on silicon tubes  
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1.2.3. Cardiac Tissue Rings 
Cardiac tissue cells or cardiomyocytes are the muscle cells of the cardiac muscles. 
The cells are paramount to unison contraction mechanism to deliver blood to various organs 
and tissues. The inability of cardiomyocytes to proliferate after birth is an obstacle to cardiac 
tissue repairs, thus cardiomyocytes are required to be derived from stem cells for cell 
transplantation. To observe cardiac tissue functions in vitro, 3D engineered cardiac tissue is 
to fabricate cardiac tissue for a specific part of the heart. For example, decellularized heart 
tissue has been executed by decellularizing whole heart and filling them with 
cardiomyocytes. The decellularization leaves ECM intact including blood vessel and 
connective tissue and eliminates cells. This method presents alternative autologous heart 
transplantation37. Another example is prefabricated matrices method referred to as a protocol 
which seeding cells into prefabricated porous solid matrices. The matrices can be 
manipulated to desired geometry such as cardiac sheet for repairing damaged heart and 
cardiac tissue ring to study biological questions38. 
Akiyama et al. have developed the cardiac tissue ring fabrication method and 
introduced the concept of seeding cardiomyocytes with magnetic particles39. This method 
used polycarbonate pole, instead of conventional PDMS or agarose mold, as illustrated in 
Figure 3.  The method begins with mixing suspended cardiomyocytes in medium containing 
MCL magnetic particles (Fe3O4; average particle size of 10nm). After that, the MCL labeled- 
cardiomyocytes are mixed with collagen solution. The mixture is cast into the well with 
polycarbonate pole in the center. Then, the cardiomyocytes are accumulated onto culture 
bottom by placing a magnet beneath the well to attract the MCL- labeled cardiomyocytes. 
The cardiomyocytes layer will be formed. Excess ECM are to be aspirated before incubating 
the remaining cardiomyocytes for an hour after which media are added. The cardiomyocyte 
layer will rapidly shrink into a cardiac tissue ring within 3-5 days.  The results suggested that 
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80% cell viability at 200 MCL pg/cell. Contractile forces were observed by inducing 
electrical pulses on the cardiac tissue ring. The replicability of the method is excellent, but 
the tissue fabricated by this method has foreign magnetic particles embedded throughout the 
tissue preventing usages in drug discovery and tissue replacement.  
 
Figure 3. Cardiomyocyte ring fabrication diagram using magnetic39. a mixture of MCL-
labeled cardiomyocytes and ECM precursor were seeded into a well with polycarbonate post. 
After that immediately, cardiomyocytes were attracted to the well bottom by placing a 
magnet under the well forming cardiomyocytes layer. Excess ECM were to be aspirated 
before adding the medium. Rapid shrinkage of cardiomyocytes sheet was occurred resulting 
in cardiomyocyte tissue ring 
1.3. Human Induced Pluripotent Stem Cell (hiPSC) Technology 
Induced pluripotent stem cells (iPSCs) are pluripotent stem cells derived from animal 
and human somatic cells by reprogramming using four factors; Oct4, Sox2, Klf4, and c–Myc. 
iPSCs were introduced in 2006 and rejuvenated the stem cell field since previously the only 
pluripotent stem cells available to researchers were embryonic stem cells (ESCs) that are 
highly controversial in ethics40. The iPSCs have differentiation potential to any cell types, 
which makes them a precious tool for stem cell research and regenerative medicine. 
Combining hiPSC technology and tissue engineering method, mimicking native tissue with 
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higher accuracy could be achieved. hiPSCs-derived tissue rings have been developed for 
engineering vascular and perivascular tissues in vitro. 
In 2016, Dash et al. have experimented on tissue-engineered vascular ring41. The team 
used improved Dikina-modified Gwyther’s method36, a scaffold-free tissue ring fabrication 
method. Briefly, hiPSC-derived vascular smooth muscle cells (hiPSC-VSMCs) were seeded 
into ring-shaped agarose well and formed tissue rings within a day after the seeding. 
Thinning and failure of the rings have been observed under the rings cultured with SmGM-2 
within 4 to 7 days, however, the problem was solved when switching media to culture 
medium with 20% FBS, PDGF-BB, and TGF-β1 one day after seeding.  A large amount of 
collagen type I was present in the rings. The average thickness was 0.84 – 0.87 mm with the 
inner diameter of 2 mm at day 14 – 17.  The stress-strain plot was drawn in Figure 4(a). 
Contractility measurement was calculated by using force required to move a ring by a 
distance of 1.14 mm divided by its cross-sectional areas (Figure 4(b)). 1 mM carbachol and 
50 mM KCl were added as an agonist to observe contractility reaction and the results were 
67.35 ± 22.7 Pa and 44.44 ± 27.13 Pa respectively for different drugs (Figure 4(c)). 
Additionally, supravalvular aortic stenosis (SVAS) hiPSC-VSMCs have been generated by 
the same protocol.  Contractility of control hiPSC-VSMCSs in response to carbachol was 
much higher than the disease hiPSC-VSMCs (42.01 ± 11.77 Pa and 5.51 ± 4.51 Pa 




Figure 4. VSMC ring from modified Gwyther’s protocol41. The top left image depicted 
the VSMC ring during the measurement (a). Stress & Strain were plotted (b).   hiPSC-
VSMCs contractility in response to agonists; carbochol and KCl (c). Healthy and diseased 
VSMC rings were compared, showing the healthy ones were stronger (d). 
1.4. Goals 
This study has 3 objectives: (1) Develop a protocol to generate tissue rings from several cell 
types (human fibroblast, hiPSC-derived MSC and hiPSC-derived cardiomyocytes); (2) 
Generate hiPSC-derived MSC tissue ring with chemical-defined culture media and achieve 











Figure 5 illustrated tissue ring fabrication protocol. Acrylonitrile butadiene styrene 
(ABS) molds were printed by a 3D printer. PDMS molds were created by using ABS molds 
to be a container for the cells suspension in collagen type I matrix with the expectation that 
cells would aggregate surrounding the post.  
 
Figure 5. Schematic of tissue ring fabrication. (1) Printing ABS mold (scale bar = 3mm), 
(2) Casting PDMS mold (scale bar = 3mm) from ABS mold, (3) seeding cells with collagen 
into the PDMS mold (scale bar = 1mm), and (4) tissue rings aggregated within a day (scale 
bar = 1mm) were illustrated. 
 
Different ABS molds could be designed to produce smaller tissue rings or multi-post 
system to produce 3D tissue structure such as triangle or ellipse. 2-post, 3-post, and 4-post 
molds were fabricated based on this concept.  PDMS and curing agent ratio were used as 10:1 
for tissue ring formation but increased to 5:1 to accommodate the multi-post system. The 
total amount of cell suspension mixture was adjusted linearly based on the volume of the 
PDMS molds. For instance, a 2-post PDMS mold was required a double amount of cells 
suspension mixture of a regular ring-shape PDMS mold.  
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2.2. PDMS Mold Fabrication 
 
Figure 6. Schematic of a ABS mold (a) and its 3D representing image (b) and the 
corresponding reversed PDMS mold (c). 
The ABS molds were designed using SolidWork, saved into STL files, and printed 
using MakerBot Replicator 2X 3D printer. The PDMS molds were designed to fit in the cell 
culture wells of the regular 24-well plate (21 mm in diameter). To fabricate PDMS molds 
with 3 mm trough and 2 mm center post designed in Figure 6, ABS molds were coated with 
silicone spray (stoner, G0093241) to help with PDMS detachment. PDMS and curing agent 
were mixed at a ratio of 10:1 (w/w) in weighing boat and poured into ABS molds. The molds 
containing PDMS were then transferred into a desiccator connecting to a vacuum pump and 
degassed for 3 hours to remove all bubbles that would negatively affect PDMS consistency. 
Next, the PDMS was cured in an oven at 60°C overnight. 
To take the PDMS molds out of the ABS molds, the edge between the solidified 
PDMS and the ABS mold was traced with an X-ACTO knife gently. The PDMS molds were 
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removed by using a mini spoon depicted in Figure 7. Finally, the PDMS molds were rinsed in 
70% Ethanol for 15 minutes for sterilization.   
 
Figure 7. Images of a mini spoon (a) used to remove PDMS mold, the ABS mold (b), and 
the PDMS mold (c). 
2.3. PDMS Mold Coating 
The Pluronic solution was used to coat PDMS molds to have a non-fouling surface. 
10% Pluronic acid was made by adding 1g of Pluronic F-127 (Pluronic® F-127, P2443) in 10 
mL of distilled water and dissolving in the oven at 50°C overnight. Then, the 10% Pluronic 
acid was sterilized using Steriflip® Filter Unit and stored at room temperature. Before 
coating PDMS molds, the PDMS molds were washed with 70% Ethanol and PBS solution 
respectively. To coat the molds, 10% Pluronic acid was poured into the molds and incubated 
for 24 hours at room temperature. 
2.4. Cell Culture  
Human fibroblast cells were cultured in low glucose DMEM supplemented with 10% 
fetal bovine serum (v/v) (Thermofisher, 10437010), 1% Glutamax (Thermofisher, 
35050061), and 1% Nonessential Amino Acids (Thermofisher, 11140076) and maintained at 
37 °C in a 5% CO2 incubator. Passaging was performed approximately every week using 
Trypsin-EDTA (Thermofisher, 25200114) at 37 °C for 5 minutes to dissociate the cells and 
then transferred 10-15% cells available into each new culture flask with the same size.  
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hiPSC-MSCs were received from Tackla Winston. hiPSC-MSCs were maintained in 
serum-free StemPro MSC medium (Life technologies, A103320) at 37 °C in a 5% CO2 
incubator. Passaging was performed approximately every week using Trypsin-EDTA 
(Thermofisher, 25200114) at 37 °C for 5 minutes to dissociate the cells and then transferred 
10-15% cells available into each new culture flask with the same size. hiPSC-CMs were 
received from Chenyan Wang. hiPSC-CMs were maintained in RPMI media supplemented 
with B-27 complete.  
2.5. Collagen preparation 
Collagen scaffold was prepared by the combination of rat tail Collagen I 
(Thermofisher, A1048301), 1N NaOH (Sigma-Aldrich, 1091371000), distilled water, and 
10X PBS (Thermofisher, AM9625) according to manufacturer’s instruction. 
 
Figure 8. Collagen mixture formula. Collagen, 10X PBS, 1N NaOH, and distilled water 
were used according to the calculation. 
Since collagen rapidly gels at room temperature, other reagents needed to be mixed in 
advance before mixing with collagen.  For instance, to produce 2 mg/ml collagen mixture for 
100 µl, 66.67 µl of 3 mg/ml rat tail collagen I, 10 µl of 10X PVS, 1.67 µl of 1N NaOH, and 
21.67 µl of distilled water were needed. NaOH, 10X PBS, and distilled water were loaded 
and mixed into a tube. When cell-suspension media was ready, the collagen was then added 
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into the same tube. 200 µl pipette tips or larger were recommended, otherwise, the procedure 
should be done on ice to avoid collagen being clogged inside the tips.  
2.6. Cell Seeding 
Cells from culture flask were trypsinized for 5 minutes in the incubator at 37 °C with 
5% CO2, the cell-suspension media was transported into a tube, and then cell culture media 
was added to the tube. Centrifuge was conducted to let cells form a pellet on the bottom. The 
supernatant was aspirated, and the cells were evenly distributed by adding new media. Cell 
counting was executed using hemocytometer. Cell-suspension media was adjusted to the 
desired concentration. For instance, to change the 2 ml cell suspension with 5 million (5 M) 
cells into the final cell concentration of 0.3 M cells per 50 µl, the media would be decreased 
to (5 M/ 0.3 M) x 50 µl = 833.33 µl. The media would be pelleted, subsequence supernatant 
would be aspirated, and 833.33 µl of media would be added. After adjusting, the cell 
suspension media was added into prepared collagen mixture with a ratio of 1:2. The cell-
collagen mixture was loaded into PDMS wells and incubated at 37 °C with 5% CO2 for 40 
minutes, and then media was filled to the top of the wells. The media were changed every 2 
days.  
2.7. Tissue Ring Extraction 
Tissue rings could be extracted out of the PDMS wells when they became strong 
enough for the extraction. Fibroblast tissue rings were extracted on day 1, hiPSC-MSCs were 
extracted on day 3 for DMEM + 10% FBS and serum-free culture media, but on day 7 for 
DMEM + 5% FBS. hiPSC-CM rings were resilient enough on day 7, but they were strongly 
attached to the posts, resulting in difficulties for the extraction. To extract tissue rings, mini 




Figure 9. The probe used for tissue ring extraction. 
2.8. Tissue Shape Measurement 
The microscopic images were captured using either 1 frame (tissue rings) or 4x4 
frames (tissue constructs) to cover the entire tissues. The tissue rings were measured at least 3 
times stochastically for thickness, inner diameter, and ring diameter, as shown in Figure 10, 
by Nikon Eclipse Ti microscope and NIS Elements software. The measurements were then 
averaged for each sample. 
 
Figure 10. Tissue rings measurement.  The tissue ring thickness and inner diameter were 
measured. 
2-post 3D tissue constructs were measured for the gap between a post and the 
structure, and deflection of the structure (D) defined direction toward the structure as positive 





Figure 11. 2-post system derived tissue shapes measurement. The gap between the post 
and the structure (G) and the deflection of the structure (D) were measured. 
3D triangle tissue constructs were measured for the gap between a post and the 
structure (G), the angle between the center line and the direction of the gap (Angle), and 
deflection (D) of the structure as shown in Figure 12. Each value was also normalized by 
dividing the value by the distance between posts. 
 
Figure 12. 3 and 4- post system derived tissue shapes measurement. The gap between 
post and the structure (G), the angle of the gap (Angle), and the deflection on each side (D) 
were measured. 
2.9. Statistics 
Each batch was analyzed with a sample size of at least 3 sample per group. The data were 
represented as means ± standard deviation. Prism 6 software (version 6.01) was used to plot 








3.1. Tissue Ring 
Previous studies had reported deriving tissue rings from scaffold-free method32,41. However, 
the reports also stated the significance of cell aggregation. Dash et al. were switched to 
collagen-promoting supplemented media, otherwise hiPSC-VSMC were failed to hold its ring 
structure within 4-7 days. This highlighted the importance of scaffold, especially collagen, to 
form a solid tissue ring. Collagen had been selected to act as a scaffold, as it is abundant in 
ECM. To seed with collagen, a container was needed to enforce collagen to retain the desired 
shape. PDMS well with a center post would be appropriate to accomplish the task. PDMS 
was our material of choice of the well because of its inert, non-toxic, reusable and clear. 3D 
printed ABS mold negative was fabricated to be used as a primary mold to manufacture 
PDMS mold. Nevertheless, a combination of the collagen-cell mixture in a PDMS mold was 
not enough to produce a tissue ring, because collagen and cells attached to the mold surface 
subsequently unsuccessful to aggregate to the center and form a ring. Pluronic F127 was 
introduced to remedy the problem by coating the mold to induce non-fouling surface on the 
mold surfaces. Fibroblasts were the first cells to be experimented to polish seeding protocol 
due to their robust nature. hiPSC-MSCs and hiPSC-CMs were later seeded by using the 
established protocol. Fibroblast, hiPSC-MSC, and hiPSC-CMs tissue rings could be seen in 
comparison in Figure 13.  
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3.1.1. Fibroblast Tissue Rings 
Experiments were completed using 0.5 M cells for each condition. Two collagen 
concentrations had been applied (0.5 and 2.0 mg/ml) to form the fibroblast tissue rings. To 
study the effect of the non-fouling surface on PDMS surface, cells were seeded into the wells 
with and without Pluronic acid coating. Each ring had been observed for a period of 14 days 
as shown in Figure 14. 
 
Figure 13. A fibroblast ring (a) comparing to hiPSC-MSC (b) and hiPSC-CM (c) rings 
(scale = 1 mm). 
 
Figure 14. A fibroblast ring from mixing method retaining its shape and size for 14 days 
(scale bar = 1 mm). 
We found higher collagen concentration yielded no significant difference in ring 
diameter with p-value = 0.1281 at Day 14 (Figure 15(a)). The average ring diameters of 0.5 
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and 2.0 mg/ml were 2.382 ± 0.687 and 3.282 ± 0.398 mm. The results suggested seeding 
with 2.0 mg/ml collagen would offer thicker tissue ring.   
Shaking and mixing protocols were introduced to establish consistent rings. Pluronic 
acid was added to detach the collagen gel from the PDMS mold. The seeded wells with 
shaking protocol were shaken for 600 RPM x 3 minutes using Labnet Vortemp 56 EVC 
Shaking Incubator. Comparing to the shaking protocol, mixing protocols described in the 
method section were resulted in larger and consistent rings as shown by the mean and 
standard deviation, shown in Figure 15(b). The results didn’t conclude any significant 
differences between each group in diameter except shaking and pluronic + mixing with p-
value = 0.0076.  The ring diameters of control, shaking, Pluronic+ shaking, and Pluronic + 
mixing groups were 3.282 ± 0.398, 2.691 ± 0.367, 3.062 ± 0.371, and 3.518 ± 0.057 mm. 
 
Figure 15. Fibroblast rings diameter varied by collagen density and fabrication 
protocol. The top left graph depicted ring diameter varying collagen concentration (a). The 
top right graph depicted the effect of Pluronic acid coating on the ring diameter (b). The 
bottom graphs showed the fibroblast rings seeded in Pluronic coated well using mixing 
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protocol and 2.0 mg/ml collagen over time and on the last day (c and d). The rings were 
measured on day 14. 
Fibroblast tissue rings fabricated from mixing protocols were characterized in detail 
in Figure 15(c), 15(d) and Figure 16. The rings retained size and shape consistently 
throughout two-week culture after the first 2 days, therefore the protocol was finalized to be 
performed for seeding hiPSC-MSCs and hiPSC-CMs. 
 
Figure 16. Fibroblast rings thickness (a) and inner diameter (b). The rings retained the 
openness over time. 
3.1.2. Asymmetrical hiPSC-CM Ring 
1 M hiPSC-CMs were seeded in each asymmetrical well to fabricate an asymmetrical 
cardiac ring imitating ventricular tissue as shown in Figure 17. Seeding with 0.3 and 0.6 M 
cells were also performed previously, but resulting in failure; cells were not able to aggregate 




Figure 17. A hiPSC-CM ring over 7 days. The ring had uneven surface unlike other cell 
types (scale = 1 mm). 
3.1.3. hiPSC-MSC Tissue Rings 
hiPSC-MSC rings fabricated using mixing protocol with Pluronic coating were 
resulted in an unexpected occurrence that the rings became solid structure (closing inner 
diameter), 2-4 days after removing from the molds at Day 3, depicted in Figure 18-19. This 
phenomenon was not reported from Dikana et al MSC rings fabricated using the scaffold-free 
method, because their rings remained in the molds and were harvested right before the 
measurement. They didn’t characterize the ring growth and morphogenetic changes after 




Figure 18. A 0.6 M hiPSC-MSC cells ring turning into a spheroid within 7 days. The ring 
was removed from the PDMS mold on day 3 cultured with DMEM + 10% FBS (scale bar = 
1mm). 
 
Figure 19. A 0.3 M hiPSC-MSC cells ring turning into a spheroid within 4 days. The ring 
was removed from the PDMS mold on day 3 (scale bar = 1mm). 
Histochemistry was performed immediately after the rings were extracted from the 
molds, showing positive MSC biomarkers of CD 90 and CD 73 and H&E staining, as 




Figure 20. Immunohistochemistry of H&E, CD73, and CD90. The top left (a) and the 
bottom left (c) pictures depicted expression of CD 90. The top right (b) was the result of 
H&E staining. The bottom right (d) exhibited a hiPSC-MSC ring expressing CD73. 
hiPSC-MSC rings were seeded in two total amounts of cells (0.3 and 0.6 M cells), 
three different collagen concentrations (0.5, 1.0, and 2.0 mg/ml) and cultured with different 
serum concentration (5% FBS and 10% FBS) and serum-free media. The rings were 
harvested on day 3, except 5% FBS groups harvested on day 7, because of insufficient 
strength to be removed from the mold in earlier days.  
Collagen concentration study had been depicted in Figure 21.  In summary, collagen 
concentration affected thickness significantly (p-value = 0.0011) with significant difference 
between 0.5 and 1.0 mg/ml groups (p-value = 0.0008). Collagen concentration also 
influenced inner diameter significantly (p-value = 0.0032) with significant differences 
between 0.5 and 2.0 mg/ml groups (p-value = 0.0192), and 1.0 and 2.0 mg/ml groups (p-
value = 0.0028). Lastly, collagen concentration impacted ring diameter (p-value = 0.0004) 
significant with significant differences among every 2 groups; 0.5 and 1.0 mg/ml (p-value = 
0.00283), 0.5 and 2.0 mg/ml (p-value = 0.0003), and 1.0 and 2.0mg/ml (p-value = 0.0304). 
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The data was also summarized in Table 2. Contrast to the Fibroblast rings which became 
thicker when seeding with higher collagen concentration, the hiPSC-MSC rings were thicker 
with lower collagen concentration. 
 
Figure 21. hiPSC-MSC rings seeded with different collagen density. The rings with 0.5 
,1.0, and 2.0 mg/ml were resulted in different thickness (a), inner diameter (b), and ring 
diameter (c). 
The effect of cell number has been investigated in Figure 22. hiPSC-MSC rings were 
seeded with two different amounts (0.3 and 0.6 M cells). Both types of the hiPSC-MSC rings 
showed a similar trend in thickness, inner diameter, and ring diameter over time (Figure 
22(a), 22(c), 22(e)). Thickness was drastically increased right after the rings were removed 
and gradually declined over time. Inner diameter was rapidly declined after the removal and 
reach to zero within 7 days for 0.6 M cells and 11 days for 0.3 M cells. Ring diameter was 
gradually shrinking at a different rate for each system over time corresponding to inner 
diameter shrinkage. However, the rings after the removal on day 3 depicted in a different 
manner. Although the two systems showed no significant difference in thickness (p-value = 
0.5131), they had the difference on inner diameter with p-value = 0.0250 and ring diameter 




Figure 22. hiPSC-MSC rings with 0.3 and 0.6 M cells. The thickness, the inner diameter, 
and the ring diameter of each cell number were shown over 11 days ((a), (c), (e)) and were 
plotted on day 3 on Figure ((b), (d), (f)). 
hiPSC-MSC rings with 0.3 M and 0.6 M cells were cultured with two different FBS 
concentrations (5.0% and 10.0%) and serum-free media to inspect the effect of different 
culture media (Figure 23). Culture media had no significant effect on thickness for both 0.3 
M (p-value = 0.2749) and 0.6 M cells (p-value = 0.4771) (Figure 23(a) and 23(b)). However, 
this did not apply to inner diameter as shown in Figure 23(c) and 23(d) (p-value = 0.0003 for 
0.3 M cells and p-value = 0.0304 for 0.6 M cells). For the hiPSC-MSC rings with 0.3 M cells, 
the statistical difference on inner diameter between 10% and 5% FBS had p-value of 0.0007, 
between 5% FBS and serum-free media had p-value of 0.0010. The tissue rings seeded with 
0.6 M cells only showed significant difference between 10% FBS and serum-free media 
groups with p-value of 0.0024. For ring diameter differences, 0.6 M cells were resulted in no 
significant difference (p-value = 0.2771) but 0.3 M cells had demonstrated significant 
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difference with p-value < 0.0001 with significant differences between 5.0% FBS to 10.0% 
FBS and serum-free media of p-value < 0.0001 for both comparisons (Figure 23(e) and 
23(f)). 
 
Figure 23. hiPSC-MSC rings with 0.3 and 0.6 M cells with different serum 
concentration. The rings cultured with 10% FBS, 5%FBS, and Serum free were plotted 
showing the thickness, the inner diameter, and the ring diameter over 11 days ((a), (c), (e)) 
and upon removal ((b), (d), (f)) (day 3 for 10%FBS and serum-free media and day 7 for 
5%FBS). 
Two-way ANOVA was performed comparing the effect of a number of cells seeded 
and serum concentration to thickness, inner diameter, and ring diameter. The result showed 
no significant differences caused by a number of cells seeded, serum concentration, and their 
interaction affecting thickness. On the other hand, significant differences in inner diameter 
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caused by serum concentration (p-value = 0.0055) and the interaction between a number of 
cells seeded and serum concentration (p-value = 0.0071) were present. Finally, ring diameter 
was not influenced by a number of cells seeded or serum concentration but influenced by the 
interaction of the two factors with a p-value of 0.0179.  
3.2.  Multi-post hiPSC-MSC 3D tissue structure 
 Mechanical stimuli were known factor affecting cell behavior. Microscopically, the 
mechanical stimuli maintain and regulate chondrocyte phenotype42. Macroscopically, the 
tissue structure could be remodeled. To understand the importance of mechanical stimuli, a 
model was needed. Our multi-post system could serve as a tool to pursue the question. The 
number of the post could be modified to provide a different kind of forces. In addition, 
hydrogel could be changed or modified to observe the interaction between the hydrogel and 
mechanical stimuli.  
 2-post system was used to represent the simple model, in which only bidirectional 
forces were presented to regulate the tissue morphology and structure. Tissue triangles 
represented a more complex model, in which forces were presented from several directions. 
The center post of the tissue triangles could be served as a stabilizer offering more evenly-
distributed forces comparing to the triangles without the center post. The deflection and the 
gap of the structure had been chosen as parameters to be measured, because of their 
observability. These parameters could be compared under different tissue geometries and 
culture conditions to understand the role of mechanical forces on tissue remodeling. 
Multi-post hiPSC-MSC 3D structures were fabricated using the same protocol as 
previous tissue rings by linearly increasing required cell suspension volume (Figure 24). 
Despite fabricating them with identical protocol, the gap between tissue and posts in 2-post 
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system was narrowing, while the gap in triangle posts was widening. In following 
experiments, three multi-post systems (2, 3, and 4 posts) had been performed. 
 
Figure 24. 2-post hiPSC-MSC oval shape and 4-post hiPSC-MSC triangle; Day-4 hiPSC-
MSC 2-post structure was shown in the figure a (the distance between the post was 4 mm) 
and day-5 hiPSC-MSC 4-post triangle was shown in figure b (the triangle was equilateral 
with 8 mm on each side and the center post point of origin was at the center of the triangle) 
(scale bar = 1 mm). 
3.2.1. 2-post hiPSC-MSC structure 
2-post hiPSC-MSC structures with 5 and 6 mm post distances had shown no 
significant differences. Deflection was gradually increasing, while the gap was decreasing in 
the same manner over time (Figure 25 and 26). 
 




Figure 26. 2-post hiPSC-MSC tissue shapes with different post distance gap and 
deflection measurements comparison over 13 days; Gap (a) and deflection (b) of 5 and 6 
mm post distance 2-post hiPSC-MSC tissue shapes portrayed no significant differences over 
time. 
3.2.2.  hiPSC-MSC triangle 
hiPSC-MSC triangles seeded in 6 mm, 8 mm with and without center post were 
experimented to study the effect of the center post and the post distance on the tissue 
remodeling (Figure 27 and Table 4).  
 
Figure 27. A triangle hiPSC-MSC tissue structure over 13 days. (scale bar = 1mm). 
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The gap was influenced by both the center post and the post distance with the 
significance of p-value = 0.0041 (Figure 28(a), 28(b)). The normalized gap between 6 and 8 
mm without the center post, which could indicate the importance of the post distance, was 
found significantly different with the p-value of 0.0069 (0.234 ± 0.032 and 0.313 ± 0.021 
mm). The normalized gap between with and without the center post (same 8 mm post 
distance), which could indicate the importance of the center post, was found significantly 
different with the p-value of 0.0054 (0.222 ± 0.031 and 0.313 ± 0.021 mm). 
Deflection was only impacted by the post distance since the existence of the center 
post did not affect the deflection as supported by Figure 28(c) and 28(d), which indicated no 
significant difference between 8mm hiPSC-MSC structure with and without the center post. 
However, the post distance influenced the deflection, since 6 mm without the center post was 
the difference to 8 mm with and without the center post indicated by the p-value of 0.0143 
and 0.0180 (0.064 ± 0.021, 0.108 ± 0.024, and 0.110 ± 0.010 mm respectively). 
Angle was not determined differently by either the presence of the center post or the 
distance between the posts as shown in Figure 28(e) and 28(f).  
Comparing the tissue remodeling characteristics between 2-post structures and 
triangle structures, the gap displayed in opposite manner, which showed that the gap of the 
triangles was increasing over time, while the gap of 2-post structures was decreasing over 
time. Yet, the deflection was increasing over time in both systems. Clearly, the mechanism 




Figure 28. hiPSC-MSC triangles with different post system angle, gap, and deflection 
measurements comparison over 13 days. The hiPSC-MSC triangles with 6 mm without 
center post, 8 mm with and without center post were measured for normalized gap, 
normalized deflection, and angle over the duration of 13 days ((a), (c), (e)) and on day 13 
((b), (d), (f)). 
4. Conclusion and Discussion 
 
 A protocol for tissue ring fabrication that can be applied to several cell types 
had been created. The protocol can be improved by minimizing tissue ring size to serve as an 
economically sound test sample for drug discovery research. One way to achieve this is to 
reduce the size of the mold. This, in turn, could bring problem concerning cell seeding, since 
the high viscosity of collagen gel would make it challenging to use smaller pipette tips lesser 
than 200 µl. Another aspect of minimizing tissue ring was the consistency. Ring cultured 
with a third size of normal tissue ring with 2mm diameter had been performed resulting in 
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geometrically inconsistent rings (data not shown). Lastly, the mold could be put together in a 
productive manner by creating a block featuring numerous wells within the block.  
 Contracture in hiPSC-MSC and fibroblast rings after the removal was also observed 
in fibroblasts with free-floating collagen model43,44. Briefly, the cell-laden collagen scaffold 
was seeded and detached from the well to observe its contracture over time, which was 
exhibited inclusively when using collagen as a scaffold44. The free-floating fibroblast-
collagen was contracting into a ball, but our fibroblast rings were contracting for 3 days after 
the removal and retained their morphology. Given that fibroblast could acquire myofibroblast 
phenotype under mechanical tension45, the situation with the fibroblast rings might be 
because fibroblasts differentiated into myofibroblasts that induced by the external force from 
the center post. If that was the case, the model could be used to study the importance of α-SM 
actin in myofibroblast to fibroblast differentiation which was not answered yet45. 
 Tissue contracture was also correlated with various cytokines. Extracellular matrix 
metalloproteinase inducer (EMMPRIN) expression increased the contractile properties in 
fibroblasts and α-SM actin production, which was a marker of myofibroblasts45. 
Transforming growth factor β (TGF-β) also induced contracture in fibroblast45, increased 
EMMPRIN output46, and enhanced rings strength36. Finally, IL (interleukin) 4 and 13 
prompted MSC-laden collagen type I gel contracture47. In future, supplementing these 
cytokines in culture media could be used to investigate the contracture across different cell 
types. 
 The majority of tissue structures were cultured by basal medium supplemented with 
an animal-derived serum that is not chemical-defined culture condition. This adds unknown 
factors for fabrication and analysis since animal serum has batch-to-batch variation leading to 
inconsistency results48 and unplanned interactions with the test subjects49,50. Furthermore, 
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tissues cultured with animal-derived serum could be exposed to the risk of (virus, bacterial, 
and fungal) contamination51,52. This risk would be eliminated if serum-free media is used. 
The serum also contains a large amount of high molecular weight protein, which is an 
uncommon environment for somatic cells53. Thus, chemical-defined culture media has been 
chosen to fabricate hiPSC-MSC rings resulting in geometrical consistency and high 
reproducibility.  
Tissues with different shapes have been fabricated from the multi-post system, which 
could be an important tool to observe and study matrix remodeling and cell contractility.  Our 
previously described structures fabricated from 2-post oval and 4-post triangle gaps 
remodeling in contrast manner; the 2-post shapes remodeled to the direction of the post, but 
the 4-post shapes remodeled in opposite direction to the posts. Yet, the deflection of these 
two shapes progressed in the same inward direction.  
Similar matrix remodeling study has been done with cardiac cells within 
collagen/fibrin 3D matrices in PDMS well platform containing 2 cantilevers on each side to 
fabricate dog-bone tissue shapes54. Dog-bone tissue shapes width changes had been observed 
over time and were explained by current stress comparing to maximum contractile stress 
(stall stress) of the cells vs strain rate relation which is like that of a sarcomere. The 
contractile stress was occurred at the junction between each adherent cell and its substrate 
and measured with traction microscopy55. Shortly, in any portion of tissue shape, if the 
portion receives the stress more than the stall stress, that portion will extend in the same axis 
of the stress and in turn narrowing that portion, and vice versa. The stress could be calculated 
from the static force from cantilevers and cross-sectional area of the tissue shape. The static 
force was derived from stiffness and deflection of the cantilevers, while cross-sectional areas 
were measured visually. Increasing cantilever stiffness would increase tissue tension and 
stress54,56. Matrix stiffness also affects the amount of stress56; the denser the matrix, the lesser 
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the stress. Surprisingly, An attempt to temporary stiffen the cantilever by attaching magnetic 
bead on the posts and using a magnetic field to counter the bending were resulted in 
increasing cell contractility of valvular interstitial cells57. The strain rate could be quantified 
by tracking the deformation on each point of the tissue shape visually. The maximal principle 
stress direction affecting cell tension was another remodeling direction indicator as the nuclei 
aligned to the direction58.  
Expanding from dog-bone shape to other shapes, Schell et al discovered that Matrix 
geometry influencing maximal principle stress directions, and in turn cell tension as observed 
by the nucleus directions which aligned to the directions58. Agarose hydrogel molds with 
different geometry, number, and position of agarose posts were seeded with chondrocytes and 
fibroblasts and used to predict the maximal principle stress directions via finite element 
method by treating the tissue as neo-Hookean material and the posts as a rigid body. The 
predicted stress directions were aligned to the nucleus directions. For instance, hexagonal 
equibiaxial shapes had the equal nucleus directions in every direction in the center as 
predicted by the calculation as do the dog-bone shapes in the rod section, which were 
predicted to have mostly horizontal stress directions. Both cell types had the same nucleus 
directions according to the mold design but the fibroblast tissue shapes, especially dog-bone 
shapes, were more deflected and elongated than the chondrocytes tissue shapes since 
fibroblasts are more contractile. 
The matrix remodeling also affects cell contractility59. The matrix with and without 
cells under magnetic force was compared and shown that the matrix with cells returned its 
former stress and strain values before the force was applied, while the matrix without cells 
did not have the same recovery ability. Polacheck and Chen explored further and found that 
the deflection of the posts/cantilevers were from the combination of cells generated forces 
within the tissue60.  With these concepts, we could explore the relation behind the matrix 
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remodeling and cell contractility using different tissue shapes by modifying post position and 
quantity, mechanical forces by varying matrix stiffness, cell types, post stiffness, and likely 
size. 
To further characterize the tissue morphology, the tissue height and volume will need 
to be measured and calculated. We have encountered some difficulties to measure the height 
directly through actin staining and upright confocal microscope, since the standing posts will 
interfere lowering down the objective for imaging the bottom of the tissues. A potential 
approach to measure the height can be completed by cutting the mold boundary and 
visualized sideway, which will sacrifice the PDMS molds. The tissue volume could be 
estimated based on the height and area measurements.  
To measure the mechanical properties of the tissue rings, the rings would be mounted 
on tensile testing machine such as Instron EPS 1000 in the horizontal position and attached 
on load cell of  1N ±1mN and custom wire grips32. The rings would be extended to tare load 
and recorded for the gauge length. After entering cross-sectional area of the rings calculated 
from tissue thickness, stress-strain curve would be ready to be plotted. Appropriate amount of 
pre-cycling would be performed, and the rings would be pull to failure. Ultimate tensile 
strength and fracture strength would be recorded, and elastic modulus would be calculated 






Table 1. Measurement of fibroblast rings cultured with 2.0 mg/ml collagen density using 








1 3.90 ± 0.42 1.04 ± 0.22 1.82 ± 0.11 6 
2 3.61 ± 0.12 1.08 ± 0.12 1.46 ± 0.17 6 
4 3.58 ± 0.20 1.12 ± 0.12 1.35 ± 0.11 6 
7 3.51 ± 0.12 1.13 ± 0.18 1.26 ± 0.26 6 
10 3.49 ± 0.13 1.10 ± 0.14 1.28 ± 0.19 6 
14 3.52 ± 0.06 1.11 ± 0.10 1.30 ± 0.18 6 
 









0.5 0.92 ± 0.08  2.37 ± 0.35 3.34 ± 0.42 5 
1.0 0.50 ± 0.19 2.65 ± 0.44 3.08 ± 0.29 5 
2.0 0.73 ± 0.08 1.59 ± 0.21 2.26 ± 0.31 4 
 
Table 3. Measurement of hiPSC-MSC rings with different cell seeding number and 
serum concentration. 
Cell Number  300,000 
  Thickness (mm) Inner Diameter (mm) Ring Diameter (mm) n 
10% FBS 0.58 ± 0.03 1.34 ± 0.17 2.50 ± 0.10 5 
5%   FBS 0.64 ± 0.08 1.81 ± 0.8  3.09 ± 0.09 5 
Serum-free 0.58 ± 0.07 13 ± 0.17 2.5 ± 0.04 4 
Cell Number  600,000 
  Thickness (mm) Inner Diameter (mm) Ring Diameter (mm) n 
10% FBS 0.68 ± 0.13 1.73 ± 0.26 3.10 ± 0.36 5 
5%   FBS 0.59 ± 0.07 1.42 ± 0.55 2.60 ± 0.56 4 










Table 4. Measurement of hiPSC-MSC triangles.    
(nG = normalized gap, nD = normalized deflection). 
  6 mm without cp 8 mm 8 mm without cp 
N 7 4 3 
Day nG Nd nG nD nG nD 
1 0.16 ± 0.01 0.00 ± 0.02 0.14 ± 0.02 0.04 ± 0.01 0.15 ± 0.03 0.03 ± 0.01 
3 0.16 ± 0.01 0.00 ± 0.01 0.13 ± 0.01 0.02 ± 0.01 0.15 ± 0.04 0.02 ± 0.00 
5 0.16 ± 0.01 0.00 ± 0.01 0.14 ± 0.01 0.03 ± 0.01 0.16 ± 0.02 0.03 ± 0.01 
7 0.19 ± 0.02 0.01 ± 0.01 0.17 ± 0.01 0.05 ± 0.01 0.18 ± 0.02 0.05 ± 0.01 
9 0.21 ± 0.04 0.04 ± 0.01 0.20 ± 0.03 0.07 ± 0.02 0.26 ± 0.05 0.08 ± 0.00 
11 0.22 ± 0.04 0.05 ± 0.02 0.21 ± 0.03 0.09 ± 0.02 0.30 ± 0.02 0.10 ± 0.01 
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